MannKind
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
CEOMichael E. Castagna
CEOMichael E. Castagna
Employees407
Employees407
HeadquartersDanbury, Connecticut
HeadquartersDanbury, Connecticut
Founded1991
Founded1991
Employees407
Employees407
MNKD Key Statistics
Market cap1.10B
Market cap1.10B
Price-Earnings ratio35.51
Price-Earnings ratio35.51
Dividend yield—
Dividend yield—
Average volume3.81M
Average volume3.81M
High today$3.67
High today$3.67
Low today$3.54
Low today$3.54
Open price$3.56
Open price$3.56
Volume2.54M
Volume2.54M
52 Week high$7.63
52 Week high$7.63
52 Week low$3.51
52 Week low$3.51
MNKD News
Simply Wall St 5d
Possible Bearish Signals With MannKind Insiders Disposing StockMany MannKind Corporation ( ) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.